European Academy of Andrology (EAA) guidelines* on investigation, treatment and monitoring of functional hypogonadism in males
ConclusionTRT can reliably improve global sexual function in men with hypogonadism in the short term. Long ‐term clinical benefits, and safety of TRT in functional hypogonadism, remain to be fully documented. Clinicians should therefore explicitly discuss the uncertainties and benefits of TRT and engage them in shared management decision‐making.
Source: Andrology - Category: Urology & Nephrology Authors: Giovanni Corona,
Dimitrios G. Goulis,
Ilpo Huhtaniemi,
Michael Zitzmann,
Jorma Toppari,
Gianni Forti,
Dirk Vanderschueren,
Frederick C. Wu,
G. Corona,
D.G. Goulis,
G. Forti,
H.M. Behre,
M. Punab,
J. Toppari,
C. Krausz,
C. Krausz,
E Rajpert Tags: REVIEW ARTICLE Source Type: research
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Eating Disorders & Weight Management | Heart | Heart Failure | Low Testosterone | Obesity | Organic | Prostate Cancer | Reproduction Medicine | Urology & Nephrology